LAVascular
Contact Us

Embolization Liquid Agents

889 devices 23 with evidence

Clinical Overview

Embolization liquid agents are used in interventional radiology to occlude blood vessels, primarily to control bleeding, treat vascular malformations, or manage tumors. These agents address clinical problems such as hemorrhage, arteriovenous malformations, and hypervascular tumors. Patients who typically require these devices include those with trauma, cancer, or vascular anomalies. Specialists using these devices are primarily interventional radiologists and vascular surgeons.
Clear Filters
Device Manufacturer Pathway Cleared Evidence
philips multidiagnost 4 Philips Medical Systems 510K 1996 419
aq hydrophilic stent Cook Urological 510K 1996 419
philips intellispace cardiovascular Evidence Philips Medical Systems Nederland 510K 2025 419
soft k and soft k toric xyloficon a soft hydrophillic keratoconus contact lens for daily wear Evidence Soflex Contact Lens Industries 510K 2002 419
polychaco fia-abs test for syphilis Parasitic Disease Consultants 510K 1983 419
philips page writer trim series cardiograph including i ii iii models 860286 860287 860288 860289 860290 860291 Philips Medical Systems 510K 2003 419
phillips radiation measuring instrument Evidence Long Island Scientific 510K 1982 419
sauflon 55 uv soft hydrophilic contact lens Sauflon Pharmaceuticals 510K 2001 419
kawasumi laboratories philebotomy set Evidence Kawasumi Laboratories 510K 2000 419
rim-haemophilus 1 2 Evidence Austin Biological Laboratories 510K 1983 419
eye secret 38 uv aspheric polymacon 1-day soft hydrophilic contact lens Yung Sheng Optical 510K 2015 419
philips viewforum 2003 Philips Medical Systems 510K 2003 419
captia r syphilis-m Mercia Diagnostics 510K 1987 419
philips bluecontrol Evidence Philips Electronics Nederland 510K 2017 419
elecsys syphilis Evidence Roche Diagnostics 510K 2021 419
clariti 1 day multifocal somofilcon a soft hydrophilic daily disposable contact lens with uv blocker Evidence Coopervision 510K 2024 419
hydrophilic coated guidewire Evidence Lake Region Mfg. 510K 1998 419
syphilis igg human serum controls Evidence Pyramid Biological 510K 1996 419
philips integris v5000 and bv5000 Philips Medical Systems North America 510K 1997 419
detectadot system 2000 heterophile test Evidence Gull Laboratories 510K 1989 419
the sensititre 20-24 hour haemophilus influenzae streptococcus pneumoniae hp mic or breakpoint susceptibility system with penicillin in the dilution range of 0 015-32 ug ml Thermo Fisher Scientific 510K 2025 419
kendall hydrophilic powder wound dressing Kendall Healthcare Products Co. Div.Of Tyco Health 510K 1997 419
quegel hydrophilic wound dressing Evidence Questor Pharma 510K 1996 419
philips ict ct system Evidence Philips Medical Systems (Cleveland) 510K 2017 419
or head holder lucy with headcoilset siemens 1 5t or head holder lucy with headcoilset siemens 3t or head holder lucy with headcoilset philips 1 5t or head holder lucy with headcoilset philips 3t Noras Mri Products 510K 2022 419
argyle neo-sert hydrophilic polyurethane umbilical vessel catheter insertion tray Sherwood Medical 510K 1995 419
immuglo anti-neutrophil cytoplasmic antibody anca test sytem Immco Diagnostics 510K 1998 419
hydron r polymacon hydrophilic contact lenses Les Laboratories Blonchard PMA 1993 419
014 hydrophilic coated pta balloon dilatation catheter Creagh Medical 510K 2017 419
philips baby thermometer set sbc sc530 Philips Consumer Electronics 510K 2002 419
philips gyroscan nt release 6 series Philips Medical Systems North America 510K 1998 419
philips angiopro release 2 1 Evidence Philips Medical Systems North America 510K 1993 419
adore polymacon daily wear soft hydrophilic contact lenses tinted color Eyemed Technologies S.R.L. 510K 2019 419
ferris hydrophilic dressing add l indications Ferris Mfg. 510K 1990 419
sheets lyophilized collagen heyedrator Evidence Pantheon Products 510K 1986 419
lake region hydrophilic guidewire Lake Region Mfg. 510K 2004 419
trust rpr test for syphilis in serum or plasma Evidence Ampcor 510K 1988 419
polyvue polymacon soft hydrophilic contact lens polyvue color polymacon soft hydrophilic contact lens Interojo 510K 2022 419
sensititre haemophilus streptococcus pneumoniae hp mic plate Trek Diagnostic Systems 510K 2001 419
hydrophilic coated guidewire Evidence Lake Region Medical 510K 2014 419
lenses benz-g 3x hioxifilcon b spherical and toric soft hydrophilic contact lenses in clear and with a blue tint Benz Research And Development 510K 1997 419
philips incisive ct Evidence Philips Healthcare (Suzhou) 510K 2018 419
giselle polymacon daily wear soft hydrophilic contact lenses clear and tinted I-Codi 510K 2015 419
bioplex 2200 syphilis igg kit on the bioplex 2200 multi-analyte detection system Bio-Rad Laboratories 510K 2007 419
hydrophilic guidewire Evidence Lake Region Mfg. 510K 2003 419
acuvue etafilcon a soft hydrophilic contact lenses clear and visibility tint with uv blocker for daily wear Evidence Vistakon, Johnson & Johnson Vision Products 510K 1999 419
asi automated rpr rapid plasma reagin test for syphilis for use on the asi evolution automated syphilis analyzer Evidence Arlington Scientific, Inc. (Asi) 510K 2020 419
philips heartstart 12 lead transfer station model 989803142521 Philips Medical Systems 510K 2007 419
philips inturis cardio image viewing package Evidence Philips Medical Systems North America 510K 1998 419
quickwire - hydrophilic coated guidewire Evidence Meadox Surgimed 510K 1991 419

Evidence Landscape

The clinical evidence for embolization liquid agents includes randomized controlled trials (RCTs), observational registries, and case series. Commonly measured outcomes are procedural success, complication rates, and long-term efficacy. Evidence is strongest in the treatment of arteriovenous malformations and tumor embolization, while data on long-term outcomes and comparative effectiveness remain areas for further research.

Device Landscape

Embolization liquid agents can be classified into several subtypes, including non-adhesive liquid embolics, adhesive agents, and sclerosants. Key differentiating features include viscosity, polymerization time, and radiopacity. Each type offers distinct handling characteristics and clinical applications, allowing for tailored treatment approaches.

Clinical Workflow Considerations

Embolization procedures using liquid agents are typically performed in angiography suites with fluoroscopic guidance. Clinicians should be trained in catheter-based techniques and familiar with the specific properties of each agent. Key decision points include selecting the appropriate agent based on the vascular anatomy and clinical objectives, as well as managing potential complications.

Frequently Asked Questions

What are embolization liquid agents used for?

Embolization liquid agents are used to occlude blood vessels in order to control bleeding, treat vascular malformations, and manage hypervascular tumors.

What clinical evidence is available for embolization liquid agents?

The evidence landscape includes RCTs, registries, and case series, focusing on procedural success, complication rates, and efficacy. Evidence quality is robust for certain indications like arteriovenous malformations.

How do I choose between different embolization liquid agents?

Clinicians consider factors such as the patient's vascular anatomy, the desired duration of occlusion, agent properties, and institutional protocols when selecting an embolization liquid agent.

What complications are associated with embolization liquid agents?

Common complications include non-target embolization and vessel perforation, while serious complications can involve tissue necrosis or systemic embolization.

What training is required for embolization liquid agents?

Training typically involves hands-on experience in catheter-based techniques, understanding agent properties, and competency in managing procedural complications.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.